LLY News and Press, Eli Lilly and Company From 05/29/24

2024-05-29 09:25:00 ET Summary Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affi...

2024-05-29 09:05:00 ET Summary Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affi...

2024-05-29 07:30:00 ET Summary Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affi...

2024-05-29 06:15:00 ET Companies with a trillion-dollar market value have several key things in common. They have a track record of earnings growth, sell products or services people depend on, and their prospects for future growth look bright. Great examples are Microsoft , Apple , ...

Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases PR Newswire New $6.5 million commitment will help strengthen systems to improve health outcomes across resource-limited areas in India GENEVA , May 2...

2024-05-29 05:20:00 ET Summary Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affi...

2024-05-28 21:19:27 ET Summary Chase Coleman's Tiger Global Management 13F portfolio value increased from $14.1B to $18.3B this quarter. The largest five positions in the portfolio are Meta Platforms, Microsoft, Alphabet, Apollo Global, and Amazon.com. New stakes include Liber...

2024-05-28 17:45:19 ET Summary Today, we take a more in-depth look at Altimmune, Inc., a biotechnology company focused on developing therapies for obesity and liver disease. The company's key asset is pemvidutide, a GLP-1 agonist that has shown some potentially promising results i...

2024-05-28 14:36:30 ET Summary Calamos Global Dynamic Income Fund offers high-income and geographic diversification, without sacrificing equity exposure. The fund's distribution yield of 9.00% is lower than its peers, but it has delivered strong recent performance and total return...

2024-05-28 10:49:02 ET More on the markets BofA says a signal to sell global equities is closer to lighting up Nasdaq, S&P, Dow are mixed following long weekend News have trended negatively against the ACWI - BofA Ignore The Weather Vanes UBS Inve...